Details of the Drug Reposition

General Information of This Drug (ID: DM5VEN9)

• Drug Name: Minnelide 001 (DM5VEN9)

Information on Drug Reposition of This Drug

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Gastric adenocarcinoma	DISWWLTC	2B72	Phase 1	[1]
Gastrointestinal cancer	DISHIGUN	2C11	Phase 1	[2]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] ClinicalTrials.gov (NCT01927965) Study of Minnelide in Patients With Advanced GI Tumors. U.S. National Institutes of Health.